Hedge Fund - Renaissance Technologies

United Therapeutics Corp (UTHR) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2025 - Q4 (2025-12-31) $930,286,448 1.44% 1,909,259 $465.69
2 2025 - Q3 (2025-09-30) $911,107,660 1.2% 2,173,392 $336.31
3 2025 - Q2 (2025-06-30) $608,921,086 0.81% 2,119,092 $298.86
4 2025 - Q1 (2025-03-31) $649,522,424 0.98% 2,106,992 $342.70
5 2024 - Q4 (2024-12-31) $737,221,073 1.09% 2,089,392 $367.56
6 2024 - Q3 (2024-09-30) $772,384,723 1.16% 2,155,392 $337.80
7 2024 - Q2 (2024-06-30) $692,748,137 1.17% 2,174,692 $264.67
8 2024 - Q1 (2024-03-31) $494,292,000 0.77% 2,151,714 $225.66
9 2023 - Q4 (2023-12-31) $477,208,000 0.73% 2,170,214 $230.49
10 2023 - Q3 (2023-09-30) $508,322,000 0.86% 2,250,508 $230.33
11 2023 - Q2 (2023-06-30) $482,827,000 0.69% 2,187,214 $221.53
12 2023 - Q1 (2023-03-31) $498,852,000 0.66% 2,227,414 $246.53
13 2022 - Q4 (2022-12-31) $651,980,000 0.89% 2,344,492 $252.44
14 2022 - Q3 (2022-09-30) $533,964,000 0.75% 2,550,214 $223.56
15 2022 - Q2 (2022-06-30) $658,282,000 0.77% 2,793,591 $203.30
16 2022 - Q1 (2022-03-31) $496,107,000 0.58% 2,765,213 $190.51
17 2021 - Q4 (2021-12-31) $630,347,000 0.78% 2,917,191 $196.31
18 2021 - Q3 (2021-09-30) $559,017,000 0.72% 3,028,591 $196.97
19 2021 - Q2 (2021-06-30) $557,999,000 0.69% 3,110,191 $190.45
20 2021 - Q1 (2021-03-31) $536,534,000 0.66% 3,207,591 $166.73
21 2020 - Q4 (2020-12-31) $547,551,000 0.59% 3,607,291 $131.23
22 2020 - Q3 (2020-09-30) $374,611,000 0.37% 3,709,018 $109.73
23 2020 - Q2 (2020-06-30) $450,945,000 0.38% 3,726,818 $112.52
24 2020 - Q1 (2020-03-31) $340,443,000 0.33% 3,590,223 $95.05
25 2019 - Q4 (2019-12-31) $312,194,000 0.23% 3,544,433 $87.99
26 2019 - Q3 (2019-09-30) $256,179,000 0.21% 3,212,278 $80.53
27 2019 - Q2 (2019-06-30) $237,379,000 0.2% 3,040,978 $93.51
28 2019 - Q1 (2019-03-31) $263,117,000 0.23% 2,241,778 $116.52
29 2018 - Q4 (2018-12-31) $239,229,000 0.26% 2,196,778 $115.95
30 2018 - Q3 (2018-09-30) $248,609,000 0.25% 1,944,078 $123.69
31 2018 - Q2 (2018-06-30) $176,084,000 0.19% 1,556,200 $109.92
32 2018 - Q1 (2018-03-31) $172,347,000 0.18% 1,533,878 $127.04
33 2017 - Q4 (2017-12-31) $216,359,000 0.23% 1,462,378 $127.12
34 2017 - Q3 (2017-09-30) $149,183,000 0.17% 1,273,000 $127.70
35 2017 - Q2 (2017-06-30) $108,662,000 0.13% 837,600 $124.75
36 2017 - Q1 (2017-03-31) $68,529,000 0.09% 506,200 $151.49
37 2016 - Q4 (2016-12-31) $60,413,000 0.09% 421,200 $127.68
38 2016 - Q3 (2016-09-30) $46,063,000 0.08% 390,100 $120.15
39 2016 - Q2 (2016-06-30) $42,823,000 0.08% 404,300 $111.55
40 2016 - Q1 (2016-03-31) $52,882,000 0.1% 474,578 $126.54
41 2015 - Q4 (2015-12-31) $86,461,000 0.18% 552,078 $145.57
42 2015 - Q3 (2015-09-30) $113,756,000 0.27% 866,778 $160.39
43 2015 - Q2 (2015-06-30) $141,174,000 0.32% 811,578 $179.89
44 2015 - Q1 (2015-03-31) $76,992,000 0.16% 446,500 $152.45
45 2014 - Q4 (2014-12-31) $23,986,000 0.05% 185,238 $128.87
46 2014 - Q3 (2014-09-30) $306,000 0% 2,378 $103.09
47 2014 - Q2 (2014-06-30) $22,342,000 0.05% 252,478 $96.17
48 2014 - Q1 (2014-03-31) $27,075,000 0.06% 287,940 $102.28
49 2013 - Q4 (2013-12-31) $25,361,000 0.06% 224,278 $90.18
50 2013 - Q3 (2013-09-30) $34,755,000 0.08% 440,778 $73.09
51 2013 - Q2 (2013-06-30) $38,859,000 0.1% 590,378 $64.42
52 2013 - Q1 (2013-03-31) $19,672,000 0.04% 323,175 $56.61
53 2012 - Q4 (2012-12-31) $0 0% 0 $52.21
54 2012 - Q3 (2012-09-30) $12,102,000 0.03% 216,578 $54.58
55 2012 - Q2 (2012-06-30) $0 0% 0 $44.14
56 2012 - Q1 (2012-03-31) $29,606,000 0.1% 628,178 $48.14
57 2011 - Q4 (2011-12-31) $40,006,000 0.16% 846,678 $41.66
58 2011 - Q3 (2011-09-30) $29,732,000 0.12% 793,078 $48.47
59 2011 - Q2 (2011-06-30) $49,005,000 0.19% 889,378 $63.31
60 2011 - Q1 (2011-03-31) $29,213,000 0.11% 435,880 $66.96
61 2010 - Q4 (2010-12-31) $16,524,000 0.06% 261,378 $60.01

The displayed share prices are average quarterly stock market prices.